🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Informist Newswire has featured Syngene in an industry article titled "Indian CDMO companies must level up for opportunity from US Biosecure Act," highlighting the potential impact of the Biosecure Act on pharmaceutical supply chains. Read the article pulse.ly/qreexfkg7n

Syngene announces Q2FY25 results. Link to the press release 👉 pulse.ly/ti4qm52skz #Q2FY25 #Syngene #Pressrelease

At Syngene, we achieved enantioselective cyclopropanation, producing 800+Kg of RSM! Read our co-published article in ACS OPRD journal 👉 cdn.syngeneintl.com/2024/10/221728…

Syngene Wishes You a Very Happy and Prosperous Diwali.

European Biopharmaceutical Review (EBR) has featured Syngene in an article titled "Biologics Roundtable: The Current Landscape and Future Developments" Read the full article: pulse.ly/lujkrwas5w #Syngene #Biologics

Wishing you and your family a Happy #Thanksgiving ☺️

Celebrating young scientific minds! 🌟Congrats to the winners of Syngene's 3rd #Synquizitive! Proud to impact 10K+ students from 200 schools, fostering curiosity & love for science! Read more cdn.syngeneintl.com/2024/12/102202… Kiran Mazumdar-Shaw Biocon Foundation Biocon Pramuch Goel Dr. Taslimarif Saiyed

Syngene wishes you and your family a happy Christmas. #MerryChristmas #HappyHolidays

The #Harvestfestival is celebrated by different names in different states across India, with equal joy and fervor. On this auspicious occasion, we wish you happiness, good health & prosperity. Wishing you all #HappyLohri #HappyBihu #HappyPongal #HappyMakarSankranti

Syngene Intl received Innovation, Business Expansion, and Environmental awards at the 2024 Excellence Awards. These accolades highlight Syngene’s advancements in drug discovery, growth in operations, and commitment to sustainability. Find out more - bit.ly/4jdNKsA

Wishing you all a very Happy Republic Day! #HappyRepublicDay2025 #RepublicDay #India

Syngene welcomes Peter Bains! With 30+ years in biotech & pharma, he previously led Syngene (2010–2016) to a successful 2015 public listing. His expertise & leadership will drive Syngene to new heights! syngeneintl.com/executive-lead…

24/7 Biopharma features Dr. Jayashree Aiyar, CSO at Syngene, in its Women in Science series, highlighting her 30-year journey and Syngene’s DE&I efforts in STEM. Read the full interview here. 247biopharma.com/article/wormen…

At Syngene, our non-GMP manufacturing of KSMs and RSMs helps accelerate small-molecule drug development with efficient sourcing, scale-up, and a dependable, agile supply chain. syngeneintl.com/solutions/smal… #Syngene #CRDMO

Driving Impact Through Clinical Research: Meet Dr. Mrinal Kammili Watch this inspiring interview to hear how Dr. Mrinal and his team are accelerating drug development—delivering innovation with heart. syngeneintl.com/solutions/disc… #ClinicalResearch #DrugDevelopment #PatientFirst

Our high-quality iPSC products & services offer a game-changing approach to disease modelling & therapy development. Generate top-tier iPSCs, ensure high quality & robustness for your research needs with our expertise. syngeneintl.com/services/disco… #iPSC #CRISPR

With over 27 years of excellence, Syngene’s Analytical Development team is a trusted partner in delivering high-quality drug products for early and late-phase drug development. syngeneintl.com/contact-us/?ut…

Advancing cell therapies isn’t just about innovation—it’s about proving safety. Explore how a biotech company navigated this step to move forward. Read now - syngeneintl.com/resources/case… #Syngene #DrugtoClinic #SafetyTox

We are excited to attend CPHI China from June 24-26, 2025, in Shanghai New International Expo Center. Meet our experts at the event to discuss how Syngene can help you accelerate your research and development programs. Book a meeting - lnkd.in/gCqrUPJU

Ensuring the quality of iPSCs is vital for successful drug discovery. We have established rigorous protocols for tissue procurement, reprogramming, and cell banking to maintain high-quality iPSCs, thereby enhancing the reliability of preclinical studies. lnkd.in/d-phMRZS